Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Natalie Cook

The University of Manchester

United Kingdom

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Pharmacotherapy

80%

Pharmacology

60%

Cancer Biology

80%

Cancer Therapy

60%

Targeted Therapy

30%

Oncology

30%

Antibiotic Therapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles24

Cancer of unknown primary: the hunt for its elusive tissue-of-origin – is it time to call off the search?

Article Link

Year:

2025

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors

Article Link

Year:

2025

A single centre experience of patients with Rare Cancers referred for Early Phase Clinical Trials

Article Link

Year:

2025

Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patients

Article Link

Year:

2025

Accelerating the Future of Oncology Drug Development

Article Link

Year:

2025

Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer

Article Link

Year:

2024

A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary

Article Link

Year:

2024

Is early-onset colorectal cancer an evolving pandemic?

Article Link

Year:

2024

Social determinants of health inequalities in early phase clinical trials in Northern England

Article Link

Year:

2024

Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials

Article Link

Year:

2024

Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours

Article Link

Year:

2024

Cross-cultural adaptation of the PROFFIT Instrument to measure financial toxicity in people living with cancer within a UK population

Article Link

Year:

2023

A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer

Article Link

Year:

2023

The Impact of Oral Antibiotics Prior to Cancer Diagnosis on Overall Patient Survival: Findings from an English Population-Based Cohort Study

Article Link

Year:

2023

Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study

Article Link

Year:

2023

Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study

Article Link

Year:

2022

Circulating tumour DNA — looking beyond the blood

Article Link

Year:

2022

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors

Article Link

Year:

2022

Epic

Article Link

Year:

2022

Antibiotic use reduces efficacy of tyrosine kinase inhibitors in patients with advanced melanoma and non-small-cell lung cancer

Article Link

Year:

2022

Antibiotic use reduces efficacy of tyrosine kinase inhibitors in patients with advanced melanoma and non-small cell lung cancer.

Article Link

Year:

2021

Discovery and Evaluation of Protein Biomarkers as a Signature of Wellness in Late-Stage Cancer Patients in Early Phase Clinical Trials

Article Link

Year:

2021

A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours

Article Link

Year:

2021

A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity

Article Link

Year:

2020

Collaborators19

Alicia-Marie Conway

The University of Manchester

UNITED KINGDOM

Darren Ashcroft

The University of Manchester

UNITED KINGDOM

Victoria Palin

The University of Manchester

UNITED KINGDOM

Syed Hussain

Professor of Medical Oncology

University of Sheffield Medical School

UNITED KINGDOM

Fiona Blackhall

The University of Manchester

UNITED KINGDOM

Ana Arance

University of Barcelona

SPAIN

Louise Carter

Clinical Senior Lecturer

The University of Manchester

UNITED KINGDOM

Silvia Riva

Associate Professor

St Mary's University

UNITED KINGDOM

William Welfare

Honorary Senior Clinical Lecturer

The University of Manchester

UNITED KINGDOM

Nicola Flaum

The University of Manchester

UNITED KINGDOM

Jorge Barriuso

The University of Manchester

UNITED KINGDOM

Min-sun song

Assistant Research Professor

City of Hope

UNITED STATES

Alastair Kerr

Head of Bioinformatics and Biostatistics

Cancer Research UK Manchester Institute

UNITED KINGDOM

Eleni Domzaridou

The University of Manchester

UNITED KINGDOM

Marek Dynowski

Head of IT and Scientific Computing

Cancer Research UK Manchester Institute

UNITED KINGDOM

S. Percy Ivy

Associate Chief

National Cancer Institute

UNITED STATES

ANTHONY D WHETTON

The University of Manchester

UNITED KINGDOM

Tjeerd van Staa

The University of Manchester

UNITED KINGDOM

Ines Pires da Silva

Senior Lecturer

University of Sydney

AUSTRALIA

How do I reach out?

Meet Kite AI